In AD, changes in miRNA expression levels are linked to key pathological features, including tau protein phosphorylation and aggregation, mitochondrial dysfunction, and the production of Aβ peptides (Praticò, 2020; Catanesi et al., 2020; Amakiri et al., 2019). Here, MAPT is linked to Alzheimer disease.